Zurich Cantonal Bank’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Hold |
18,829
| – | – | ﹤0.01% | 2102 |
|
|
2025
Q1 | $224K | Buy |
18,829
+2,260
| +14% | +$26.8K | ﹤0.01% | 2042 |
|
|
2024
Q4 | $312K | Buy |
16,569
+1,401
| +9% | +$26.4K | ﹤0.01% | 1922 |
|
|
2024
Q3 | $341K | Sell |
15,168
-39
| -0.3% | -$876 | ﹤0.01% | 1801 |
|
|
2024
Q2 | $317K | Buy |
15,207
+13,444
| +763% | +$281K | ﹤0.01% | 1793 |
|
|
2024
Q1 | $25.9K | Buy |
+1,763
| New | +$25.9K | ﹤0.01% | 2613 |
|
|
2023
Q4 | – | Sell |
-5,482
| Closed | -$43.1K | – | 2769 |
|
|
2023
Q3 | $43.1K | Sell |
5,482
-1
| -0% | -$8 | ﹤0.01% | 2626 |
|
|
2023
Q2 | $54.8K | Hold |
5,483
| – | – | ﹤0.01% | 2593 |
|
|
2023
Q1 | $48.7K | Sell |
5,483
-829
| -13% | -$7.36K | ﹤0.01% | 2601 |
|
|
2022
Q4 | $69.3K | Buy |
6,312
+1,194
| +23% | +$13.1K | ﹤0.01% | 2486 |
|
|
2022
Q3 | $67K | Hold |
5,118
| – | – | ﹤0.01% | 2474 |
|
|
2022
Q2 | $65K | Hold |
5,118
| – | – | ﹤0.01% | 2480 |
|
|
2022
Q1 | $72K | Buy |
5,118
+1,071
| +26% | +$15.1K | ﹤0.01% | 2418 |
|
|
2021
Q4 | $117K | Buy |
+4,047
| New | +$117K | ﹤0.01% | 2423 |
|